Table 5.
Summary of the impact of each treatment scenario at 2020
| 2020 outcomes | Total HCV cases | HCV-related fibrosis | HCV-related cirrhosis | HCV-related decompensated cirrhosis | HCV-related HCC | HCV-related liver related deaths |
|---|---|---|---|---|---|---|
| Base case |
122000 |
107000 |
12600 |
1140 |
640 |
570 |
| (80300 – 153000) |
(69900 – 138000) |
(5560 – 20600) |
(470 – 2050) |
(320 – 1180) |
(260–970) |
|
| Increasing diagnosis and treatment | 89400 |
83500 |
4850 |
410 |
310 |
280 |
| (52300 – 122000) | (48900 – 116000) | (2050 – 10400) | (160 – 980) | (140 – 700) | (120 – 600) |